Updated bivalent mRNA vaccines Comirnaty and Spikevax target Omicron subvariants BA.4 and BA.5.
New Drugs
Novel drugs approved by regulators for human use.
A drug is positioned as new if it:
- offers treatment for a disease for which no specific therapy previously existed
- targets a new therapeutic target
- has a new mechanism of action
- is developed in a new formulation, optimized or improved
- is part of a new combination drug
- belongs to a new class of drug compounds.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Tecvayli: New Drug for Multiple Myeloma
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Posted inNeuroscience, New Drugs, Regulatory
Auvelity: New Antidepressant for Most Severe Depression
Dextromethorphan and bupropion: A powerful drug combination that will help with depression that cannot be treated with standard antidepressants.
Posted inCOVID-19, Infections, New Drugs, Regulatory
First Omicron Vaccine Appears
Spikevax bivalent Original / Omicron (elasomeran + imelasomeran; mRNA-1273.214) by Moderna is the world’s first vaccine to protect against the Omicron variant of the SARS-CoV-2 coronavirus.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Zoryve: New Effective Cream for Psoriasis
Roflumilast will cure plaque psoriasis in half of patients.
Posted inNew Drugs, Regulatory
Vuity: First Pharmacological Treatment for Presbyopia
Pilocarpine by Allergan and AbbVie is the first drug for age-related farsightedness.
Posted inAutoimmune Diseases, New Drugs, Regulatory
Opzelura: New Treatment for Vitiligo
Ruxolitinib cream will help most patients treat nonsegmental vitiligo.